262 related articles for article (PubMed ID: 22470485)
1. Ocular application of the kinin B1 receptor antagonist LF22-0542 inhibits retinal inflammation and oxidative stress in streptozotocin-diabetic rats.
Pouliot M; Talbot S; Sénécal J; Dotigny F; Vaucher E; Couture R
PLoS One; 2012; 7(3):e33864. PubMed ID: 22470485
[TBL] [Abstract][Full Text] [Related]
2. Expression, distribution and function of kinin B
Hachana S; Bhat M; Sénécal J; Huppé-Gourgues F; Couture R; Vaucher E
Br J Pharmacol; 2018 Mar; 175(6):968-983. PubMed ID: 29285756
[TBL] [Abstract][Full Text] [Related]
3. Retinal plasma extravasation in streptozotocin-diabetic rats mediated by kinin B(1) and B(2) receptors.
Abdouh M; Talbot S; Couture R; Hasséssian HM
Br J Pharmacol; 2008 May; 154(1):136-43. PubMed ID: 18311190
[TBL] [Abstract][Full Text] [Related]
4. Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology.
Kern TS; Miller CM; Du Y; Zheng L; Mohr S; Ball SL; Kim M; Jamison JA; Bingaman DP
Diabetes; 2007 Feb; 56(2):373-9. PubMed ID: 17259381
[TBL] [Abstract][Full Text] [Related]
5. Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats.
Kumar B; Gupta SK; Srinivasan BP; Nag TC; Srivastava S; Saxena R; Jha KA
Microvasc Res; 2013 May; 87():65-74. PubMed ID: 23376836
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant-Rich Extract from Plantaginis Semen Ameliorates Diabetic Retinal Injury in a Streptozotocin-Induced Diabetic Rat Model.
Tzeng TF; Liu WY; Liou SS; Hong TY; Liu IM
Nutrients; 2016 Sep; 8(9):. PubMed ID: 27649243
[TBL] [Abstract][Full Text] [Related]
7. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina.
Masuzawa K; Goto K; Jesmin S; Maeda S; Miyauchi T; Kaji Y; Oshika T; Hori S
Curr Eye Res; 2006 Jan; 31(1):79-89. PubMed ID: 16421022
[TBL] [Abstract][Full Text] [Related]
8. Effects of Trigonella foenum-graecum (L.) on retinal oxidative stress, and proinflammatory and angiogenic molecular biomarkers in streptozotocin-induced diabetic rats.
Gupta SK; Kumar B; Nag TC; Srinivasan BP; Srivastava S; Gaur S; Saxena R
Mol Cell Biochem; 2014 Mar; 388(1-2):1-9. PubMed ID: 24242137
[TBL] [Abstract][Full Text] [Related]
9. Key role for spinal dorsal horn microglial kinin B1 receptor in early diabetic pain neuropathy.
Talbot S; Chahmi E; Dias JP; Couture R
J Neuroinflammation; 2010 Jun; 7(1):36. PubMed ID: 20587056
[TBL] [Abstract][Full Text] [Related]
10. Hesperidin prevents retinal and plasma abnormalities in streptozotocin-induced diabetic rats.
Shi X; Liao S; Mi H; Guo C; Qi D; Li F; Zhang C; Yang Z
Molecules; 2012 Nov; 17(11):12868-81. PubMed ID: 23117428
[TBL] [Abstract][Full Text] [Related]
11. Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal Müller cells.
Lin M; Chen Y; Jin J; Hu Y; Zhou KK; Zhu M; Le YZ; Ge J; Johnson RS; Ma JX
Diabetologia; 2011 Jun; 54(6):1554-66. PubMed ID: 21360191
[TBL] [Abstract][Full Text] [Related]
12. Blockade of early and late retinal biochemical alterations associated with diabetes development by the selective bradykinin B1 receptor antagonist R-954.
Catanzaro O; Labal E; Andornino A; Capponi JA; Di Martino I; Sirois P
Peptides; 2012 Apr; 34(2):349-52. PubMed ID: 22369720
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats.
Hofni A; El-Moselhy MA; Taye A; Khalifa MM
Eur J Pharmacol; 2014 Dec; 744():173-82. PubMed ID: 25446917
[TBL] [Abstract][Full Text] [Related]
14. Early upregulation of kinin B1 receptors in retinal microvessels of the streptozotocin-diabetic rat.
Abdouh M; Khanjari A; Abdelazziz N; Ongali B; Couture R; Hasséssian HM
Br J Pharmacol; 2003 Sep; 140(1):33-40. PubMed ID: 12967932
[TBL] [Abstract][Full Text] [Related]
15. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B; Sun JH; Xiang FF; Liu L; Li WJ
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[TBL] [Abstract][Full Text] [Related]
16. The effects of anti-VEGF and kinin B
Hachana S; Fontaine O; Sapieha P; Lesk M; Couture R; Vaucher E
Br J Pharmacol; 2020 May; 177(9):1949-1966. PubMed ID: 31883121
[TBL] [Abstract][Full Text] [Related]
17. Cellular localization of kinin B1 receptor in the spinal cord of streptozotocin-diabetic rats with a fluorescent [Nalpha-Bodipy]-des-Arg9-bradykinin.
Talbot S; Théberge-Turmel P; Liazoghli D; Sénécal J; Gaudreau P; Couture R
J Neuroinflammation; 2009 Mar; 6():11. PubMed ID: 19323833
[TBL] [Abstract][Full Text] [Related]
18. Bradykinin Type 1 Receptor - Inducible Nitric Oxide Synthase: A New Axis Implicated in Diabetic Retinopathy.
Othman R; Vaucher E; Couture R
Front Pharmacol; 2019; 10():300. PubMed ID: 30983997
[TBL] [Abstract][Full Text] [Related]
19. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
[TBL] [Abstract][Full Text] [Related]
20. Enhanced dermal and retinal vascular permeability in streptozotocin-induced type 1 diabetes in Wistar rats: blockade with a selective bradykinin B1 receptor antagonist.
Lawson SR; Gabra BH; Guérin B; Neugebauer W; Nantel F; Battistini B; Sirois P
Regul Pept; 2005 Jan; 124(1-3):221-4. PubMed ID: 15544863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
